Background illustration for clinical trials search

Lupus Clinical Trials

Browse 173 Lupus clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Boston MA, Hackensack NJ, Tampa FL, Atlanta GA,
Sponsor: Kelonia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07075185

Phase 1, Recruiting
Active & Responsive

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

for
Autoimmune Disorders
Location: Baltimore MD, Birmingham AL, Chicago IL, Rochester MN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT07103746

Phase 2, Recruiting
Active & Responsive

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

for
Common Variable Immunodeficiency (CVID),
Location: Pittsburgh PA
Sponsor: Paul Szabolcs

Sex: All

Age: 5 - 40

Code: NCT07284641

Phase 2, Recruiting
Active & Responsive

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

for
Insulin Dependent Diabetes Mellitus,
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 12+

Code: NCT07348432

Recruiting
Active & Responsive

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

for
Lupus Nephritis
Location: Columbus OH, Lawrenceville GA, Atlanta GA,
Sponsor: NephroNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225387

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study

for
IgA Nephropathy (IgAN), IgA Vasculitis,
Location: Boston MA, Cincinnati OH
Sponsor: Pediatric Nephrology Research Consortium

Sex: All

Age: 0 - 18

Code: NCT07931170

Recruiting

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

for
Autoimmune Disorders, Systemic Sclerosis,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06434363

Phase 1, Phase 2, Recruiting

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

for
Autoimmune Diseases, Pregnancy Related,
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 0+

Code: NCT03276923

Recruiting

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

for
Ankylosing Spondylitis, Autoimmune Disease, Crohn Disease,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04751396

Recruiting

ILD-SARDs Registry and Biorepository

for
Interstitial Lung Disease, Systemic Autoimmune Disease,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT05007340

Recruiting

The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions

for
Rheumatic Diseases, Inflammatory Arthritis,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 60+

Code: NCT07278609

Recruiting

Rheumatology Diet Study

for
Diet Habit, Rheumatologic Disease, Autoimmune Diseases,
Location: Orlando FL
Sponsor: University of Central Florida

Sex: All

Age: 18 - 65

Code: NCT06339957

Recruiting

Research Accelerated by You Lupus Registry

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN),
Location: Washington D.C. DC
Sponsor: Lupus Foundation of America

Sex: All

Age: 0+

Code: NCT06927219

Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

for
SLE (Systemic Lupus), Lupus Erythematosus, Systemic,
Location: Boston MA, Chapel Hill NC, Chicago IL, New Orleans LA,
Sponsor: CRISPR Therapeutics

Sex: All

Age: 18 - 70

Code: NCT06925542

Phase 1, Recruiting

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

for
SLE, Systemic Lupus Erythematosus (SLE), CAR T Cell, CART19,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10 - 29

Code: NCT06839976

Phase 1, Phase 2, Recruiting

US Zamto-cel Autoimmune Diseases

for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Milwaukee WI
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT06708845

Phase 1, Recruiting

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

for
Nephritis, Lupus, Lupus Erythematosus, Systemic
Location: Miami FL, Miami Lakes FL, Doral FL, Kissimmee FL,
Sponsor: Viatris Innovation GmbH

Sex: All

Age: 18 - 70+

Code: NCT07201129

Phase 3, Recruiting

Safety and Efficacy of ONT01 in Lupus

for
Lupus Nephritis (LN), Lupus Nephritis - WHO Class III,
Location: New York NY
Sponsor: Hospital for Special Surgery, New York

Sex: All

Age: 18+

Code: NCT07107659

Early Phase 1, Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus, Lupus Nephritis
Location: Boston MA, Worcester MA, Montreal, Philadelphia PA,
Sponsor: Cabaletta Bio

Sex: All

Age: 12 - 65

Code: NCT06121297

Phase 1, Phase 2, Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: New York NY, Philadelphia PA, Durham NC, Miami FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase 1, Recruiting

What is lupus?

Lupus is an autoimmune disease in which the immune system attacks the body's own tissues. Systemic lupus erythematosus, or SLE, the most common type, can affect the skin, joints, kidneys, blood, heart, lungs, and brain, and typically comes in flares of fatigue, joint pain, rashes, and fever. Women of childbearing age are at highest risk, and Black and American Indian or Alaska Native women are two to three times more likely than White women to develop it. Cutaneous lupus affects mainly the skin, and kidney involvement is covered on our lupus nephritis page. Treatment starts with hydroxychloroquine and adds steroids, immune suppressants, and biologics as needed; belimumab, approved in 2011, was the first new lupus drug in more than 50 years.

Lupus overlaps with other autoimmune disorders such as scleroderma and rheumatoid arthritis. Cell therapy is explained on our CAR T cell therapy page.

Types of lupus clinical trials

Who can participate in lupus clinical trials?

Forms of lupus, and why they matter for trials

How to enroll in a lupus clinical trial